FAQ
MOTS-c peptide FAQ
Direct answers to the most-asked questions about the MOTS-c peptide — benefits, safety, dosing in research, half-life, and legal status — each answered from the published record and cited where quantitative.
What does the MOTS-c peptide do?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide that inhibits the folate cycle to activate AMPK, improving glucose handling in skeletal muscle, and can translocate to the nucleus to regulate stress-response genes [1][3]. A 2024 study identified casein kinase 2 (CK2) as a direct molecular target [10].
What are the negative side effects of MOTS-c?
No human safety trials of exogenous MOTS-c have been completed, so a clinical side-effect profile is not established [4]. All dosing and tolerability data come from rodent studies. The honest answer is that the human evidence needed to characterize side effects does not yet exist.
What are the potential benefits of MOTS-c?
Research-stage benefits seen in animals and cells include improved insulin sensitivity, enhanced physical capacity, adipose thermogenesis, and muscle and islet protection [1][2][7]. None is confirmed in human trials. The human evidence base is observational biomarker data — levels the body produced, associated with outcomes — not interventional results from giving the peptide to people.
What are the downsides of MOTS-c?
The main limitations are the absence of human efficacy and safety trials, no validated human pharmacokinetics, unregulated research-chemical purity, and anti-doping prohibition for athletes [4]. Several findings are also single-lab or await independent replication, and a diabetogenic mtDNA variant (m.1382A>C) suggests effects may differ across populations [4].
Is MOTS-c hard on the liver?
No human hepatotoxicity data exist for MOTS-c, so this question cannot be answered from the published animal and cell literature [4]. The studies that exist measured metabolic and performance endpoints, not human hepatic safety. Any statement that it is or is not hard on the liver in people would go beyond the evidence.
Is MOTS-c bad for the liver?
No human liver-safety data exist [4]. The published literature does not address human hepatic effects, so any claim about liver harm or safety in people would go beyond the evidence. The honest answer is that the studies needed to assess human liver effects have not been done.
Can MOTS-c cause weight gain?
In mice MOTS-c prevented diet-induced obesity rather than causing weight gain, and it has been associated with adipose thermogenic activation [1][7]. No human body-weight outcome data exist, so weight effects in people — gain or loss — have not been measured in any clinical study.
How does MOTS-c make you feel?
No human experiential data are published [4]. Subjective effects cannot be characterized from the preclinical literature, which measures metabolic and performance outcomes in animals and cells rather than how people feel. Reports of subjective effects online are anecdotal and are not part of the peer-reviewed record.
How long does it take for MOTS-c to kick in?
There is no human onset timeline [4]. In studies, effects are measured in animals over days to weeks of repeated dosing rather than as a single rapid response [1][2]. Because no human protocol has been run, any specific time-to-effect figure for people is not supported by the literature.
How long does MOTS-c take to work?
Animal studies measure metabolic and performance changes over days to weeks of dosing rather than after a single dose [1][2]. There is no validated human timeline, because no human protocol has been run. The preclinical pattern is repeated dosing over time, not a rapid one-off effect.
Does MOTS-c work immediately?
No. Even in animal models, metabolic and performance effects develop over repeated dosing rather than from a single immediate response [1][2]. There is no evidence of an immediate effect in people, because no human study has tested onset or any other clinical endpoint.
What are the top peptides for muscle growth?
This site covers MOTS-c specifically and does not rank or recommend peptides. MOTS-c itself is studied for muscle preservation rather than hypertrophy: in animals and human cells it reduced myostatin and muscle-atrophy signaling [10]. It is not an approved muscle-building drug, and no human muscle-growth trial of it exists.
What should you not mix with peptides?
No human combination-safety data exist for MOTS-c [4]. The literature does not establish interaction guidance for human use, so any mixing advice would go beyond what the evidence supports. Questions about combining substances are clinical matters outside the scope of this editorial research digest.
How often do you inject MOTS-c?
There is no human dosing schedule. Rodent studies used daily or thrice-weekly intraperitoneal injection (for example, 0.5-15 mg/kg), and those frequencies cannot be translated to people [1][2]. MOTS-c is not approved for human use, so no injection schedule for people has been established in any clinical study.
Can I inject MOTS-c every day?
Daily intraperitoneal dosing has been used in rodent research, but no human dosing frequency is established and MOTS-c is not approved for human use [1][4]. The animal frequencies describe laboratory protocols in mice and rats; they are not guidance for people and do not convert to a human regimen.
How long should you take MOTS-c?
Study durations in animals ranged from about one week to twelve weeks [1][2][4]. There is no human treatment-duration guidance, because no human protocol exists. The durations reported are features of individual rodent experiments, not a recommended course of use for people.
Does MOTS-c help with type 2 diabetes or blood sugar?
In animal and cell studies MOTS-c improved glucose handling and insulin sensitivity, and a 2025 rat study restored cardiac mitochondrial respiration with lower fasting glucose [1][12]. There are no human efficacy trials, so this is research-stage only. In people, the evidence is limited to observational associations, not treatment outcomes [11].
Does MOTS-c burn fat?
In mice MOTS-c prevented diet-induced obesity and increased adipose thermogenic activation [1][7]. Human fat-loss outcomes have not been tested, so fat-burning in people is not established. The animal findings describe prevention of weight gain on a high-fat diet rather than active fat loss in an already-lean or human body.
Is MOTS-c legal to buy?
MOTS-c is not FDA-approved and is sold only as a research chemical for laboratory use; it is not a dietary supplement or an approved medicine [16]. It is named on the FDA PCAC agenda for July 23-24, 2026 as a substance being considered for the 503A bulks list — a scheduled evaluation, not a change in current status [18]. See the full legal status page for detail.
Can I get MOTS-c over the counter?
No. MOTS-c is not an approved drug or dietary supplement and is not sold over the counter, only as a research chemical for laboratory use [16]. There is no consumer formulation, no labeled dose, and no FDA-approved indication, so it cannot be purchased the way an OTC product or supplement would be.
Where can I buy MOTS-c peptide online in the USA?
MOTS-c is sold only by research suppliers for laboratory use, and product identity, purity, and sterility vary by supplier because it is not regulated as a pharmaceutical [16]. This site is an editorial research digest: it summarizes the published literature and the regulatory landscape, and it does not sell, source, or recommend any vendor.
Is MOTS-c banned by WADA or USADA for athletes?
MOTS-c is treated as a prohibited peptide and metabolic-modulator in elite sport; athlete use can result in anti-doping sanctions [4]. Anti-doping bodies classify it among agents prohibited at all times, so its anti-doping status is a meaningful caveat for any competing athlete regardless of its research-stage standing elsewhere.
Is MOTS-c legal?
MOTS-c is not an FDA-approved drug and is not a dietary supplement; it is sold only as a research chemical [16]. It is named on the FDA PCAC agenda for July 23-24, 2026 as a substance being considered for the 503A bulks list — a scheduled evaluation, not a change in current status [18].
Can you get MOTS-c from a compounding pharmacy?
Legally compounded medicines require a valid, patient-specific prescription from a licensed prescriber and an ingredient eligible under the bulk-substance rules [16]. MOTS-c is not on the 503A bulks list and is under FDA evaluation, so it is not eligible for routine 503A compounding while that status stands [16][18].
What is the FDA 503A status of MOTS-c?
MOTS-c is not on the FDA 503A bulks list and is not an FDA-approved drug; it is scheduled for PCAC evaluation at the July 23-24, 2026 meeting [18]. A bulk substance qualifies for 503A compounding only via a USP/NF monograph, status as a component of an approved drug, or listing on the bulks list — none of which currently applies [16].